Effects of Class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe

Author： D'Alonzo A.J.   Zhu J.L.   Darbenzio R.B.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.369, Iss.1, 1999-03, pp. : 57-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Benefit-Risk Assessment of Class III Antiarrhythmic Agents

By Brendorp B.  

Drug Safety, Vol. 25, Iss. 12, 2002-01 ,pp. : 847-865

Adis International

Access to resources Recommend Favorite

A benefit–risk assessment of class III antiarrhythmic agents

By Elming Hanne   Brendorp Bente   Pehrson Steen   Pedersen Ole Dyg   Køber Lars   Torp-Petersen Christian  

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 559-577

Informa Healthcare

Access to resources Recommend Favorite

Effects of sematilide, a novel class III antiarrhythmic agent, on membrane currents in rabbit atrial myocytes

By Ishii Y.   Muraki K.   Kurihara A.   Imaizumi Y.   Watanabe M.  

European Journal of Pharmacology, Vol. 331, Iss. 2, 1997-07 ,pp. : 295-302

Elsevier

Access to resources Recommend Favorite

Evaluation of the Rabbit Purkinje Fibre Assay as an in vitro Tool for Assessing the Risk of Drug-Induced Torsades de Pointes in Humans

By Aubert Marion  

Drug Safety, Vol. 29, Iss. 3, 2006-01 ,pp. : 237-254

Adis International

Access to resources Recommend Favorite

Novel Antiarrhythmic Compounds with Combined Class IB and Class III Mode of Action

By  

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 61-69

Bentham Science Publishers

Access to resources Recommend Favorite